68Ga-JH12

N/A

Report date: 2026/03/26 20:00:17

NME

Base Information

Drug Name68Ga-JH12

Drug Alias Name68Ga-JH12

ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Gallium > 68Ga +[4]

Mechanisms of ActionC-X-C motif chemokine receptor 4 modulatorsPositron-emission tomography enhancers

TargetsC-X-C motif chemokine receptor 4

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesBivision Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Fujian Medical University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A